"In June of 2010, the AIDS Treatment Activist Coalition (ATAC)...

  1. 76 Posts.
    "In June of 2010, the AIDS Treatment Activist Coalition (ATAC) and European AIDS Trials Group (EATG) sent an open letter to Susan Cox, PhD, Chief Scientific Officer of Avexa, Nathan Droma, Chair of Avexa and Stephen Kerr, the Company’s Board Secretary that was published on TheBody.com requesting that Avexa reconsider their decision to stop the development of ATC due to the critical need for this drug. "

    http://www.hivplusmag.com/research/...itive-people-need-hiv-drug-still-not-approved


    I find this very interesting reading
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.